Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials.

Humans Nephrolithiasis / drug therapy Randomized Controlled Trials as Topic Sodium-Glucose Transporter 2 Inhibitors / pharmacology
Hyperuricemia Meta-analysis Nephrolithiasis SGLT-2 inhibitors

Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 10 05 2019
revised: 17 07 2019
accepted: 05 08 2019
pubmed: 12 8 2019
medline: 26 11 2019
entrez: 12 8 2019
Statut: ppublish

Résumé

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) decreased serum uric acid in type 2 diabetes. Hyperuricemia is associated with an increased risk of nephrolithiasis. The present meta-analysis, performed on trials with duration ≥52 weeks in comparison with placebo or active comparators, suggests no effects of SGLT-2i on the risk of nephrolithiasis.

Identifiants

DOI: 10.1016/j.diabres.2019.107808 PMID: 31401152
pubmed: 31401152
pii: S0168-8227(19)30633-3
doi: 10.1016/j.diabres.2019.107808
pii:
doi:

Substances chimiques

Sodium-Glucose Transporter 2 Inhibitors 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

107808

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Claudia Cosentino (C)

Diabetology, Careggi Hospital and University of Florence, Italy.

Ilaria Dicembrini (I)

Diabetology, Careggi Hospital and University of Florence, Italy.

Besmir Nreu (B)

Diabetology, Careggi Hospital and University of Florence, Italy.

Edoardo Mannucci (E)

Diabetology, Careggi Hospital and University of Florence, Italy.

Matteo Monami (M)

Diabetology, Careggi Hospital and University of Florence, Italy. Electronic address: matteo.monami@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Nephrolithiasis and sodium-glucose...
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Urolithiase › Néphrolithiase › Nephrolithiasis and sodium-glucose...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › Essais cliniques contrôlés comme sujet › Essais contrôlés randomisés comme sujet › Nephrolithiasis and sodium-glucose...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hypoglycémiants › Inhibiteurs du cotransporteur sodium-glucose de type 2 › Nephrolithiasis and sodium-glucose...